levamisole has been researched along with Pancytopenia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, S; Ge, M; Han, M; Jiang, E; Liu, J; Liu, L; Pei, X; Wang, J; Wang, M; Zhao, F; Zheng, Y | 1 |
| Chang, TF; Lin, CJ; Lu, SY | 1 |
| Paulus, HE | 1 |
3 other study(ies) available for levamisole and Pancytopenia
| Article | Year |
|---|---|
Levamisole Suppresses CD4
Topics: Anemia, Aplastic; Animals; Antigen-Presenting Cells; CD4-Positive T-Lymphocytes; Cell Proliferation; Disease Models, Animal; Levamisole; Mice; Pancytopenia; Retrospective Studies; Signal Transduction; Toll-Like Receptor 7 | 2022 |
Treatment effectiveness of levamisole plus prednisolone on oral lichen planus patients with emphasis on levamisole-induced agranulocytosis or pancytopenia.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Agranulocytosis; Female; Humans; Levamisole; Lichen Planus, Oral; Male; Middle Aged; Pancytopenia; Prednisolone; Treatment Outcome | 2019 |
An overview of benefit/risk of disease modifying treatment of rheumatoid arthritis as of today.
Topics: Arthritis, Rheumatoid; Azathioprine; Chloroquine; Cyclophosphamide; Female; Gold; Humans; Hydroxychloroquine; Levamisole; Macular Degeneration; Male; Neoplasms; Pancytopenia; Penicillamine; Risk | 1982 |